T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNgamma production.
EBV is associated with a broad range of malignancies. Adoptive immunotherapy of these tumors with EBV-specific CTL proved useful. We generated a panel of primary human T cells specific to various EBV antigens (i.e. Epstein-Barr nuclear antigen 3A, 3B and BamHI-M leftward reading frame) via transfer...
Main Authors: | Schaft, N, Lankiewicz, B, Drexhage, J, Berrevoets, C, Moss, D, Levitsky, V, Bonneville, M, Lee, S, Mcmichael, A, Gratama, J, Bolhuis, R, Willemsen, R, Debets, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas.
by: Rühl, J, et al.
Published: (2019) -
Cloning and expression of Epstein-Barr viral antigens in Escherichia coli : purification of recombinant EBV antigens for diagnostic application
by: Fones-Tan, Angela.
Published: (2009) -
CD161(++)CD8(+) T cells express IFNgamma in response to TLR8 stimulation in an IL-12(+) IL-18 dependent, TCR independent, manner
by: Willberg, C, et al.
Published: (2012) -
The efficiency of antigen recognition by CTL is determined by the frequency of serial TCR engagement.
by: Hudrisier, D, et al.
Published: (1998) -
Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells.
by: Setterblad, N, et al.
Published: (2004)